{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:11:11Z","timestamp":1779095471535,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GTN 2027497"],"award-info":[{"award-number":["GTN 2027497"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023360","name":"St Vincent's Hospital Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025190","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003747","name":"Department of Health, State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Justice"],"DOI":"10.1186\/s40352-026-00411-6","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:06:36Z","timestamp":1777374396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C no more: a prospective single-arm study to evaluate the effectiveness of a nurse and peer-led mobile model of hepatitis C testing and treatment at community corrections offices"],"prefix":"10.1186","volume":"14","author":[{"given":"Samara","family":"Griffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Papaluca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacinta A","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Craigie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Dicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sione","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Callus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Belzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Spelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Stoov\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"411_CR1","unstructured":"Abbott Point of Care. (n.d.). BiolineTM HCV. Available from: https:\/\/www.globalpointofcare.abbott\/ww\/en\/product-details\/bioline-hcv.html"},{"key":"411_CR2","unstructured":"Australian Bureau of Statistics. (2025). Corrective Services, Australia. Available from: https:\/\/www.abs.gov.au\/statistics\/people\/crime-and-justice\/corrective-services-australia\/latest-release"},{"key":"411_CR3","doi-asserted-by":"publisher","unstructured":"Bah, R., Sheehan, Y., Li, X., Dore, G. J., Grebely, J., Lloyd, A. R., et al. (2024). Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study. The Lancet Regional Health\u2013Western Pacific, 53. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101240","DOI":"10.1016\/j.lanwpc.2024.101240"},{"key":"411_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugpo.2018.08.011","volume":"61","author":"S Bajis","year":"2018","unstructured":"Bajis, S., Maher, L., Treloar, C., Hajarizadeh, B., Lamoury, F. M. J., Mowat, Y., et al. (2018). Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia. The International Journal on Drug Policy,61, 23\u201330. https:\/\/doi.org\/10.1016\/j.drugpo.2018.08.011","journal-title":"The International Journal on Drug Policy"},{"issue":"1","key":"411_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1186\/s12889-023-16017-8","volume":"23","author":"CR Balsom","year":"2023","unstructured":"Balsom, C. R., Farrell, A., & Kelly, D. V. (2023). Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs - a scoping review of the qualitative evidence. BMC Public Health,23(1), 1038. https:\/\/doi.org\/10.1186\/s12889-023-16017-8","journal-title":"BMC Public Health"},{"issue":"1","key":"411_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/pubmed\/fdv023","volume":"38","author":"CG Beckwith","year":"2016","unstructured":"Beckwith, C. G., Kurth, A. E., Bazerman, L. B., Patry, E. J., Cates, A., Tran, L., et al. (2016). A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections. J Public Health Oxf.,38(1), 130\u2013137. https:\/\/doi.org\/10.1093\/pubmed\/fdv023. PubMed Central PMCID: PMC4750523.","journal-title":"J Public Health Oxf."},{"key":"411_CR7","unstructured":"Biolytical Laboratories Inc. (n.d.). INSTI HCV Antibody Test. Available from: https:\/\/www.insti.com\/hcv-antibody-test\/"},{"key":"411_CR8","doi-asserted-by":"publisher","first-page":"102755","DOI":"10.1016\/j.drugpo.2020.102755","volume":"80","author":"J Broad","year":"2020","unstructured":"Broad, J., Mason, K., Guyton, M., Lettner, B., Matelski, J., & Powis, J. (2020). Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada. International Journal of Drug Policy,80, 102755. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102755","journal-title":"International Journal of Drug Policy"},{"key":"411_CR9","doi-asserted-by":"publisher","unstructured":"Burnet Institute and Kirby Institute. (2025). Australia\u2019s progress towards hepatitis C elimination: Annual Report 2025. UNSW Sydney. Report No. Available from: http:\/\/hdl.handle.net\/1959.4\/106273. https:\/\/doi.org\/10.26190\/UNSWORKS\/31756. Cited 2025 Dec 10","DOI":"10.26190\/UNSWORKS\/31756"},{"key":"411_CR10","doi-asserted-by":"publisher","unstructured":"Cabezas, J., Llerena, S., Mateo, M., \u00c1lvarez, R., Cobo, C., Gonz\u00e1lez, V., et al. (2021). Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences. Diagnostics, 11(5). https:\/\/doi.org\/10.3390\/diagnostics11050877. PubMed Central PMCID: PMC8155928","DOI":"10.3390\/diagnostics11050877"},{"issue":"3","key":"411_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan, A. W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., G\u00f8tzsche, P. C., Krle\u017ea-Jeri\u0107, K., et al. (2013). SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Annals of Internal Medicine,158(3), 200\u2013207. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583","journal-title":"Annals of Internal Medicine"},{"key":"411_CR12","unstructured":"Corrections, Prisons and Parole. (n.d.). Corrections Victoria. Cited 2025 Feb 21. Find a Community Correctional Services (CCS) location. Available from: https:\/\/www.corrections.vic.gov.au\/community-corrections\/find-a-community-correctional-services-ccs-location"},{"issue":"1","key":"411_CR13","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1186\/s12889-023-17066-9","volume":"23","author":"J Dawe","year":"2023","unstructured":"Dawe, J., Hughes, M., Christensen, S., Walsh, L., Richmond, J. A., Pedrana, A., et al. (2023). Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: A mixed-methods evaluation of the Tasmanian Eliminate Hepatitis C Australia Outreach Project, 2020\u20132022. BMC Public Health,23(1), 2289. https:\/\/doi.org\/10.1186\/s12889-023-17066-9. PubMed Central PMCID: PMC10662700.","journal-title":"BMC Public Health"},{"issue":"5","key":"411_CR14","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/s2214-109x(23)00057-8","volume":"11","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt, L., Webb, P., Colledge-Frisby, S., Ireland, J., Wheeler, A., Ottaviano, S., et al. (2023). Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Global Health,11(5), e659\u2013e672. https:\/\/doi.org\/10.1016\/s2214-109x(23)00057-8","journal-title":"Lancet Global Health"},{"key":"411_CR15","doi-asserted-by":"publisher","first-page":"104185","DOI":"10.1016\/j.drugpo.2023.104185","volume":"121","author":"J Demant","year":"2023","unstructured":"Demant, J., Krohn-Dehli, L., Van der Veen, J., \u00d8vrehus, A., Lazarus, J. V., & Weis, N. (2023). Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark. International Journal of Drug Policy,121, 104185. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104185","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"411_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1001\/jamainternmed.2022.0170","volume":"182","author":"B Eckhardt","year":"2022","unstructured":"Eckhardt, B., Mateu-Gelabert, P., Aponte-Melendez, Y., Fong, C., Kapadia, S., Smith, M., et al. (2022). Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial. JAMA Internal Medicine,182(5), 494\u2013502. https:\/\/doi.org\/10.1001\/jamainternmed.2022.0170. PubMed Central PMCID: PMC8922207.","journal-title":"JAMA Internal Medicine"},{"key":"411_CR17","unstructured":"Gastroenterological Society of Australia. (2022). Australian recommendations for the management of hepatitis C virus infection: a consensus statement. Report No. Available from: https:\/\/hepcguidelines.org.au\/"},{"issue":"3","key":"411_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/s2468-1253(22)00355-7","volume":"8","author":"J Grebely","year":"2023","unstructured":"Grebely, J., Markus, C., Causer, L. M., Silk, D., Comben, S., Lloyd, A. R., et al. (2023). A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia. Lancet Gastroenterol Hepatol.,8(3), 204\u2013207. https:\/\/doi.org\/10.1016\/s2468-1253(22)00355-7","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"411_CR19","doi-asserted-by":"publisher","unstructured":"Grebely, J., Matthews, S., Causer, L. M., Feld, J. J., Cunningham, P., Dore, G., et al. (2024). We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what? Expert Review of Molecular Diagnostics, 1-15. https:\/\/doi.org\/10.1080\/14737159.2023.2292645","DOI":"10.1080\/14737159.2023.2292645"},{"key":"411_CR20","doi-asserted-by":"publisher","first-page":"101139","DOI":"10.1016\/j.lanwpc.2024.101139","volume":"48","author":"S Griffin","year":"2024","unstructured":"Griffin, S., Lee Wilkinson, A., Winter, R., Hajarizadeh, B., MacIsaac, M., Papaluca, T., et al. (2024). Contribution of prison-based hepatitis C treatment initiations to overall treatment uptake in Victoria, Australia. The Lancet Regional Health - Western Pacific,48, 101139. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101139","journal-title":"The Lancet Regional Health - Western Pacific"},{"issue":"7","key":"411_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s2468-1253(21)00077-7","volume":"6","author":"B Hajarizadeh","year":"2021","unstructured":"Hajarizadeh, B., Grebely, J., Byrne, M., Marks, P., Amin, J., McManus, H., et al. (2021). Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): A prospective cohort study. The Lancet Gastroenterology & Hepatology,6(7), 533\u2013546. https:\/\/doi.org\/10.1016\/s2468-1253(21)00077-7","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"2","key":"411_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics,42(2), 377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"Journal of Biomedical Informatics"},{"key":"411_CR23","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O\u2019Neal, L., et al. (2019). The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics,95, 103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","journal-title":"Journal of Biomedical Informatics"},{"issue":"1","key":"411_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12954-023-00780-3","volume":"20","author":"MRA Hassan","year":"2023","unstructured":"Hassan, M. R. A., Chan, H. K., Nordin, M., Yahya, R., Sulaiman, W. R. W., Merican, S. A. A., et al. (2023). Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs. Harm Reduction Journal,20(1), 48. https:\/\/doi.org\/10.1186\/s12954-023-00780-3","journal-title":"Harm Reduction Journal"},{"key":"411_CR25","unstructured":"Hepatitis Queensland. (2024). Community Corrections Project. Available from: https:\/\/www.hepqld.asn.au\/our-project\/community-corrections\/#:~:text=The%20Hepatitis%20Queensland%20Community%20Corrections,options%20and%20hepatitis%20C%20treatment. Cited 2025 Sep 2"},{"issue":"2","key":"411_CR26","doi-asserted-by":"publisher","first-page":"ofab636","DOI":"10.1093\/ofid\/ofab636","volume":"9","author":"KF Kamis","year":"2022","unstructured":"Kamis, K. F., Wyles, D. L., Minturn, M. S., Scott, T., McEwen, D., Hurley, H., et al. (2022a). Hepatitis C testing and linkage to care among adults on probation in a large US city. Open Forum Infectious Diseases,9(2), ofab636. https:\/\/doi.org\/10.1093\/ofid\/ofab636","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"411_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40352-022-00191-9","volume":"10","author":"KF Kamis","year":"2022","unstructured":"Kamis, K. F., Wyles, D. L., Minturn, M. S., Scott, T., McEwen, D., Hurley, H., et al. (2022b). A retrospective, descriptive study of hepatitis C testing, prevalence, and care continuum among adults on probation. Health & Justice,10(1), 26. https:\/\/doi.org\/10.1186\/s40352-022-00191-9","journal-title":"Health & Justice"},{"key":"411_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1475-9276-12-18","volume":"12","author":"JF Levesque","year":"2013","unstructured":"Levesque, J. F., Harris, M. F., & Russell, G. (2013). Patient-centred access to health care: Conceptualising access at the interface of health systems and populations. International Journal for Equity in Health,12, 18. https:\/\/doi.org\/10.1186\/1475-9276-12-18","journal-title":"International Journal for Equity in Health"},{"issue":"6","key":"411_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5694\/mja2.51885","volume":"218","author":"MB MacIsaac","year":"2023","unstructured":"MacIsaac, M. B., Whitton, B., Hubble, A., Cogger, S., Penn, M., Weeks, A., et al. (2023). Eliminating hepatitis C in Australia: A novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility. Medical Journal of Australia,218(6), 256\u2013261. https:\/\/doi.org\/10.5694\/mja2.51885","journal-title":"Medical Journal of Australia"},{"key":"411_CR30","doi-asserted-by":"publisher","unstructured":"MacIsaac, M. B., Papaluca, T., McDonald, L., Craigie, A., Edwards, A., Layton, C., et al. (2024). Long-term outcomes of a decentralized, nurse-led, statewide model of care for hepatitis C among people in prison in Victoria, Australia. Clinical Infectious Diseases. https:\/\/doi.org\/10.1093\/cid\/ciae471","DOI":"10.1093\/cid\/ciae471"},{"issue":"11","key":"411_CR31","doi-asserted-by":"publisher","first-page":"e0207226","DOI":"10.1371\/journal.pone.0207226","volume":"13","author":"A Madden","year":"2018","unstructured":"Madden, A., Hopwood, M., Neale, J., & Treloar, C. (2018). Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs? PLoS One,13(11), e0207226. https:\/\/doi.org\/10.1371\/journal.pone.0207226","journal-title":"PLoS One"},{"issue":"1","key":"411_CR32","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1186\/s12913-025-13664-y","volume":"25","author":"K Maynard","year":"2025","unstructured":"Maynard, K., Houdroge, F., Thompson, R., Hawkes, A. L., Pedrana, A., Richmond, J. A., et al. (2025). Costing analysis of a Queensland community corrections hepatitis C screening program. BMC Health Services Research,25(1), 1606. https:\/\/doi.org\/10.1186\/s12913-025-13664-y","journal-title":"BMC Health Services Research"},{"issue":"1","key":"411_CR33","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1038\/s41598-023-33925-2","volume":"13","author":"M Mu\u00f1oz-Chimeno","year":"2023","unstructured":"Mu\u00f1oz-Chimeno, M., Valencia, J., Rodriguez-Recio, A., Cuevas, G., Garcia-Lugo, A., Manzano, S., et al. (2023). HCV, HIV AND HBV rapid test diagnosis in non-clinical outreach settings can be as accurate as conventional laboratory tests. Science and Reports,13(1), 7554. https:\/\/doi.org\/10.1038\/s41598-023-33925-2","journal-title":"Science and Reports"},{"key":"411_CR34","doi-asserted-by":"publisher","first-page":"103203","DOI":"10.1016\/j.drugpo.2021.103203","volume":"94","author":"A Palmer","year":"2021","unstructured":"Palmer, A., Papaluca, T., Stoov\u00e9, M., Winter, R., Pedrana, A., Hellard, M., et al. (2021). A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison. International Journal of Drug Policy,94, 103203. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103203","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"411_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jhep.2019.01.012","volume":"70","author":"T Papaluca","year":"2019","unstructured":"Papaluca, T., McDonald, L., Craigie, A., Gibson, A., Desmond, P., Wong, D., et al. (2019). Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care. Journal of Hepatology,70(5), 839\u2013846. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.012","journal-title":"Journal of Hepatology"},{"issue":"8","key":"411_CR36","doi-asserted-by":"publisher","first-page":"ofac350","DOI":"10.1093\/ofid\/ofac350","volume":"9","author":"T Papaluca","year":"2022","unstructured":"Papaluca, T., Craigie, A., McDonald, L., Edwards, A., Winter, R., Hoang, A., et al. (2022). Care navigation increases initiation of hepatitis C treatment after release from prison in a prospective randomized controlled trial: The C-LINK study. Open Forum Infectious Diseases,9(8), ofac350. https:\/\/doi.org\/10.1093\/ofid\/ofac350","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"411_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/s2468-1253(20)30366-6","volume":"6","author":"A Pedrana","year":"2021","unstructured":"Pedrana, A., Munari, S., Stoov\u00e9, M., Doyle, J., & Hellard, M. (2021). The phases of hepatitis C elimination: Achieving WHO elimination targets. Lancet Gastroenterology & Hepatology,6(1), 6\u20138. https:\/\/doi.org\/10.1016\/s2468-1253(20)30366-6","journal-title":"Lancet Gastroenterology & Hepatology"},{"issue":"4","key":"411_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/sga.0000000000000458","volume":"43","author":"JA Richmond","year":"2020","unstructured":"Richmond, J. A., Gallagher, L., McDonald, L., O\u2019Sullivan, M., Fitzsimmons, C., & Pedrana, A. (2020). Achieving hepatitis C elimination by using person-centered, nurse-led models of care: A discussion of four International Case Studies. Gastroenterology Nursing,43(4), 303\u2013309. https:\/\/doi.org\/10.1097\/sga.0000000000000458","journal-title":"Gastroenterology Nursing"},{"issue":"8","key":"411_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5694\/mja2.50544","volume":"212","author":"N Scott","year":"2020","unstructured":"Scott, N., Sacks-Davis, R., Wade, A. J., Stoove, M., Pedrana, A., Doyle, J. S., et al. (2020). Australia needs to increase testing to achieve hepatitis C elimination. Medical Journal of Australia,212(8), 365\u2013370. https:\/\/doi.org\/10.5694\/mja2.50544","journal-title":"Medical Journal of Australia"},{"issue":"3","key":"411_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jhep.2023.04.019","volume":"79","author":"Y Sheehan","year":"2023","unstructured":"Sheehan, Y., Cunningham, E. B., Cochrane, A., Byrne, M., Brown, T., McGrath, C., et al. (2023). A \u201cone-stop-shop\u201d point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study. Journal of Hepatology,79(3), 635\u2013644. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.019","journal-title":"Journal of Hepatology"},{"issue":"1","key":"411_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12874-021-01380-0","volume":"21","author":"AC Stewart","year":"2021","unstructured":"Stewart, A. C., Cossar, R., Walker, S., Wilkinson, A. L., Quinn, B., Dietze, P., et al. (2021a). Strategies to maximise study retention and limit attrition bias in a prospective cohort study of men reporting a history of injecting drug use released from prison: The prison and transition health study. BMC Medical Research Methodology,21(1), 185. https:\/\/doi.org\/10.1186\/s12874-021-01380-0","journal-title":"BMC Medical Research Methodology"},{"key":"411_CR42","doi-asserted-by":"publisher","first-page":"108970","DOI":"10.1016\/j.drugalcdep.2021.108970","volume":"227","author":"AC Stewart","year":"2021","unstructured":"Stewart, A. C., Cossar, R. D., Wilkinson, A. L., Quinn, B., Dietze, P., Walker, S., et al. (2021b). The prison and transition health (PATH) cohort study: Prevalence of health, social, and crime characteristics after release from prison for men reporting a history of injecting drug use in Victoria, Australia. Drug and Alcohol Dependence,227, 108970. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108970","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"411_CR43","doi-asserted-by":"publisher","first-page":"e0235445","DOI":"10.1371\/journal.pone.0235445","volume":"15","author":"MW Traeger","year":"2020","unstructured":"Traeger, M. W., Pedrana, A. E., van Santen, D. K., Doyle, J. S., Howell, J., Thompson, A. J., et al. (2020). The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services. PLoS One,15(6), e0235445. https:\/\/doi.org\/10.1371\/journal.pone.0235445","journal-title":"PLoS One"},{"issue":"3","key":"411_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jcrimjus.2012.03.001","volume":"40","author":"MG Vaughn","year":"2012","unstructured":"Vaughn, M. G., DeLisi, M., Beaver, K. M., Perron, B. E., & Abdon, A. (2012). Toward a criminal justice epidemiology: Behavioral and physical health of probationers and parolees in the United States. Journal of Criminal Justice,40(3), 165\u2013173. https:\/\/doi.org\/10.1016\/j.jcrimjus.2012.03.001","journal-title":"Journal of Criminal Justice"},{"key":"411_CR45","unstructured":"Victorian State Government, Justice and Community Safety- Corrections Victoria. (2026). Monthly time series prison and Community Corrections data. Available from: https:\/\/www.corrections.vic.gov.au\/about-the-corrections-system\/statistics-and-research\/monthly-time-series-prison-and-community. Cited 2026 Feb 26"},{"key":"411_CR46","doi-asserted-by":"publisher","first-page":"103019","DOI":"10.1016\/j.drugpo.2020.103019","volume":"88","author":"KM Ward","year":"2021","unstructured":"Ward, K. M., McCormick, S. D., Sulkowski, M., Latkin, C., Chander, G., & Falade-Nwulia, O. (2021). Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: A qualitative exploration. International Journal of Drug Policy,88, 103019. https:\/\/doi.org\/10.1016\/j.drugpo.2020.103019","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"411_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/v14030497","volume":"14","author":"RJ Winter","year":"2022","unstructured":"Winter, R. J., Holmes, J. A., Papaluca, T. J., & Thompson, A. J. (2022). The importance of prisons in achieving hepatitis C elimination: Insights from the Australian experience. Viruses,14(3), 497. https:\/\/doi.org\/10.3390\/v14030497","journal-title":"Viruses"},{"key":"411_CR48","doi-asserted-by":"publisher","first-page":"102548","DOI":"10.1016\/j.eclinm.2024.102548","volume":"70","author":"RJ Winter","year":"2024","unstructured":"Winter, R. J., Griffin, S., Sheehan, Y., Nguyen, W., Stoov\u00e9, M., Lloyd, A. R., et al. (2024). People in community corrections are a population with unmet need for viral hepatitis care. eClinicalMedicine,70, 102548. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102548","journal-title":"eClinicalMedicine"},{"key":"411_CR49","unstructured":"World Health Organization. (2022). Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Report No. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/strategies\/global-health-sector-strategies"}],"container-title":["Health & Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40352-026-00411-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-026-00411-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-026-00411-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:47:31Z","timestamp":1779094051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40352-026-00411-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1186\/s40352-026-00411-6","relation":{},"ISSN":["2194-7899"],"issn-type":[{"value":"2194-7899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the St Vincent\u2019s Hospital Melbourne Human Research Ethics Committee (ref:025\/023).People eligible to participate in the study will be formally consented inside the van. Trained study staff will provide a detailed overview of the contents of the Participant Informed Consent Form (PICF), and a detailed overview of the study.Potential participants will be reminded that participation is entirely voluntary, and any questions that arise will be answered by study staff. Potential participants will be asked to provide written consent via the PICF, which will be recorded and stored online via REDCap. Participants will be asked to consent to have their survey data linked to Medicare and Pharmaceutical Benefits Scheme data, to monitor hepatitis C testing, positivity, and treatment via other providers to determine if treatment was accessed from an alternate health service in the event of loss-to-follow-up, and to observe new primary and reinfections. Participants will also be asked to consent to linkage to Corrections Victoria data, to monitor future periods of incarceration and determine if testing and\/or treatment was accessed while incarcerated.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JAH has received investigator-initiated funding from Gilead Sciences, speaker fees from AbbVie and consultancy fees from CSL Behring. ACr has received professional development support from Gilead Sciences. BR has received professional development support from Gilead Sciences. SW is supported by an Australian Research Council Discovery Early Career Researcher Award (#DE240101056). MH has received investigator-initiated funding from Gilead Sciences and AbbVie. AJT has received consulting fees from Gilead, Abbvie, Roche Diagnostics, Assembly Biosciences, speaker fees from Gilead Sciences, Roche Diagnostics and investigator-initiated grants to institution from Gilead Sciences. MS has received investigator-initiated research grants from Abbvie and Gilead and consultancy from Gilead. RW has received investigator-initiated funding from Gilead Sciences. All other authors have no conflicts to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}